The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Adenosine-Mediated Effects of Ticagrelor
Open accessAbstract
This review constitutes a critical evaluation of recent publications that have described an additional mode of action of the P2Y12 receptor antagonist ticagrelor. The effect is mediated by inhibition of the adenosine transporter ENT1 (type 1 equilibrative nucleoside transporter), which provides protection for adenosine from intracellular metabolism, thus increasing its concentration and biological activity, particularly at sites of ischemia and tissue injury where it is formed. Understanding the mode of action of ticagrelor is of particular interest given that its clinical profile, both in terms of efficacy and adverse events, differs from that of thienopyridine P2Y12 antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790 · cited 5×
“Prasugrel was also superior to clopidogrel in preventing the same composite endpoint in patients with ACS who underwent PCI in the TRITON trial (4).”
BackgroundMethodInfluentialTurnover of adenosine in plasma of human and dog blood
Moser, G. H., Schrader, J., & Deussen, A. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.4.c799 · Cited by 529
The Role of Monocytes in Angiogenesis and Atherosclerosis
Jaipersad, A. S., Lip, G. Y. H., Silverman, S., & Shantsila, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.019 · Cited by 451
Regulation of Inflammation by Adenosine
Haskó, G., & Cronstein, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00085 · Cited by 367
Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes
Belardinelli, L., Shryock, J. C., Song, Y., Wang, D., & Srinivas, M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896004 · Cited by 289
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
Bonello, L., Laine, M., Kipson, N., Mancini, J., Helal, O., Fromonot, J., Gariboldi, V., Condo, J., Thuny, F., Frere, C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.067 · Cited by 283
Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
Teng, R., Oliver, S., Hayes, M. A., & Butler, K. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032250 · Cited by 264
Regulation of Neutrophil Function by Adenosine
Barletta, K. E., Ley, K., & Mehrad, B. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226845 · Cited by 260
Mustafa, S. J., Morrison, R. R., Teng, B., & Pelleg, A. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-89615-9_6 · Cited by 251
Armstrong, D., Summers, C., Ewart, L., Nylander, S., Sidaway, J. E., & van Giezen, J. J. J. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413511693 · Cited by 245
Self-citationSpringthorpe, B., Bailey, A., Barton, P., Birkinshaw, T. N., Bonnert, R. V., Brown, R. C., Chapman, D., Dixon, J., Guile, S. D., Humphries, R. G., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.057 · Cited by 235
Cardiovascular adenosine receptors: Expression, actions and interactions
Headrick, J. P., Ashton, K. J., Rose'Meyer, R. B., & Peart, J. N. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.002 · Cited by 228
Hausenloy, D. J., Bøtker, H. E., Condorelli, G., Ferdinandy, P., Garcia-Dorado, D., Heusch, G., Lecour, S., van Laake, L. W., Madonna, R., Ruiz-Meana, M., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt004 · Cited by 228
Self-citationGerczuk, P. Z., & Kloner, R. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.054 · Cited by 211
Storey, R. F., Becker, R. C., Harrington, R. A., Husted, S., James, S. K., Cools, F., Steg, P. G., Khurmi, N. S., Emanuelsson, H., Cooper, A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr231 · Cited by 207
van Giezen, J. J. J., Sidaway, J., Glaves, P., Kirk, I., & Björkman, J.-A. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411410883 · Cited by 198
Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
Wittfeldt, A., Emanuelsson, H., Brandrup-Wognsen, G., van Giezen, J. J. J., Jonasson, J., Nylander, S., & Gan, L.-M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.032 · Cited by 198
Self-citationThe platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
Cattaneo, M. (2011) · Blood · doi:10.1182/blood-2010-08-263111 · Cited by 191
Self-citationStorey, R. F., Bliden, K. P., Patil, S. B., Karunakaran, A., Ecob, R., Butler, K., Teng, R., Wei, C., Tantry, U. S., & Gurbel, P. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.062 · Cited by 186
Storey, R. F., James, S. K., Siegbahn, A., Varenhorst, C., Held, C., Ycas, J., Husted, S. E., Cannon, C. P., Becker, R. C., Steg, P. G., et al. (2014) · Platelets · doi:10.3109/09537104.2013.842965 · Cited by 162
Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism
Nylander, S., Femia, E. A., Scavone, M., Berntsson, P., Asztély, A.-K., Nelander, K., Löfgren, L., Nilsson, R. G., & Cattaneo, M. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12360 · Cited by 152
Self-citationPlatelet P2Y 12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
Yang, X., Liu, Y., Cui, L., Yang, X., Liu, Y., Tandon, N. N., Kambayashi, J., Downey, J. M., & Cohen, M. V. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412467692 · Cited by 147
Scirica, B. M., Cannon, C. P., Emanuelsson, H., Michelson, E. L., Harrington, R. A., Husted, S., James, S. K., Katus, H. A., Pais, P., Raev, D. H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.056 · Cited by 133
A2B Adenosine Receptors Protect against Sepsis-Induced Mortality by Dampening Excessive Inflammation
Csóka, B., Németh, Z. H., Rosenberger, P., Eltzschig, H. K., Spolarics, Z., Pacher, P., Selmeczy, Z., Koscsó, B., Himer, L., Vizi, E. S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901295 · Cited by 132
Adenosine and the treatment of supraventricular tachycardia
RANKIN, A. C., Brooks, R., Ruskin, J. N., & McGovern, B. A. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90784-9 · Cited by 122
A new role for the A2b adenosine receptor in regulating platelet function
Yang, D., CHEN, H., Koupenova, M., Carroll, S. H., Eliades, A., Freedman, J. E., Toselli, P. A., & Ravid, K. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03769.x · Cited by 102
Why does ticagrelor induce dyspnea?
Faioni, E. M., & Cattaneo, M. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0547 · Cited by 98
Self-citationAngiolillo, D. J., Curzen, N. P., Gurbel, P. A., Vaitkus, P. T., Lipkin, F., Li, W., Jakubowski, J. A., Zettler, M. E., Effron, M. B., & Trenk, D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.032 · Cited by 94
Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection
Rose, J. B., Naydenova, Z. G., Bang, A., Eguchi, M., Sweeney, G., Choi, D., Hammond, J. R., & Coe, I. R. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00711.2009 · Cited by 90
Adenosine Receptors and Reperfusion Injury of the Heart
Headrick, J. P., & Lasley, R. D. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_7 · Cited by 87
Cardiovascular effects of adenosine infusion in man and their modulation by dipyridamole
Biaggioni, I., Onrot, J., Hollister, A. S., & Robertson, D. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90401-7 · Cited by 87
Zhou, X., Huang, Y., Khalil, M. K., Wiktor, D. M., van Giezen, J. J. J., Penn, M. S., & Wang, K. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-12-0823 · Cited by 69
Talukder, M. A. H., Morrison, R. R., Jacobson, M. A., Jacobson, K. A., Ledent, C. A., & Mustafa, S. J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00964.2001 · Cited by 69
Alexopoulos, D. K., Μούλιας, Α., Koutsogiannis, N., Xanthopoulou, I., Kakkavas, A. T., Mavronasiou, E., Davlouros, P. A., & Hahalis, G. N. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.113.000293 · Cited by 65
Physiological implications of adenosine receptor‐mediated platelet aggregation
Johnston‐Cox, H., Yang, D., & Ravid, K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22379 · Cited by 64
Ticagrelor Improves Peripheral Arterial Function in Patients with a Previous Acute Coronary Syndrome
Törngren, K., Öhman, J. N., Salmi, H., Larsson, J., & Erlinge, D. (2013) · Cardiology · doi:10.1159/000347122 · Cited by 62
Endogenous Adenosine Increases Coronary Flow by Activation of Both A2A and A2B Receptors in Mice
Talukder, M. A. H., Morrison, R. R., Ledent, C. A., & Mustafa, S. J. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200304000-00008 · Cited by 60
Role of Adenosine and Nitric Oxide on the Mechanisms of Action of Dipyridamole
Gamboa, A. C., Abraham, R. L., Diedrich, A., Shibao, C. A., Paranjape, S. Y., Farley, G., & Biaggioni, I. (2005) · Stroke · doi:10.1161/01.str.0000179044.37760.9d · Cited by 60
Zaza, A., Rocchetti, M., & DiFrancesco, D. (1996) · Circulation · doi:10.1161/01.cir.94.4.734 · Cited by 53
Dipyridamole augments the antiinflammatory response during human endotoxemia
Ramakers, B. P., Riksen, N. P., Stal, T. H., Heemskerk, S., van den Broek, P., Peters, W. H. M., van der Hoeven, J. G., Smits, P., & Pickkers, P. (2011) · Critical Care · doi:10.1186/cc10576 · Cited by 48
Role of A1adenosine receptor in the regulation of coronary flow
Tawfik, H. E., Teng, B., Morrison, R. R., Schnermann, J. B., & Mustafa, S. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01319.2005 · Cited by 41
Mechanisms Potentially Contributing to the Reduction in Mortality Associated With Ticagrelor Therapy
Schneider, D. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.016 · Cited by 37
Adenosine A2A and A3 Receptors Are Involved in the Human Endothelial Progenitor Cells Migration
Fernández, P., Jara, C., Aguilera, V., Caviedes-Cárdenas, L., Diaz, F., Radojkovic, C., Veas, C., Lamperti, L., Escudero, C., & Aguayo, C. R. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182471d14 · Cited by 36
Singh, M., Shah, T., Khosla, K., Singh, P. P., Molnár, J., Khosla, S., & Arora, R. R. (2012) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944712446670 · Cited by 35
Serebruany, V. L. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0180 · Cited by 26
Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin
Ye, Y., Long, B., Qian, J., Perez-Polo, J. R., & Birnbaum, Y. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6252-x · Cited by 26
Additive renal effects of indomethacin and dipyridamole in man.
Seideman, P., Sollevi, A., & Fredholm, B. B. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03052.x · Cited by 18
Wallentin, L. C., Becker, R. C., Cannon, C. P., Held, C., Himmelmänn, A., Husted, S., James, S. K., Katus, H. A., Mahaffey, K. W., Pieper, K. S., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.003 · Cited by 13
Pokov, I., Kuliczkowski, W., Vahabi, J., Atar, D., & Serebruany, V. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-05-0291 · Cited by 8
Cited by
Hausenloy, D. J., Garcia-Dorado, D., Bøtker, H. E., Davidson, S. M., Downey, J., Engel, F. B., Jennings, R., Lecour, S., Leor, J., Madonna, R., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx049 · Cited by 356
Self-citationNovel antiplatelet agents in acute coronary syndrome
Franchi, F., & Angiolillo, D. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.156 · Cited by 353
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo, D. A., Galli, M., Collet, J.-P., Kastrati, A., & O'Donoghue, M. O. (2022) · EuroIntervention · doi:10.4244/eij-d-21-00904 · Cited by 299
Mega, J. L., & Simon, T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60243-4 · Cited by 284
Goto, S., Huang, C.-H., Park, S.-J., Emanuelsson, H., & Kimura, T. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0112 · Cited by 279
Metadata
- Authors
- Cattaneo, M., Schulz, R., & Nylander, S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 63
- Issue
- 23
- Pages
- 2503-2509
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W136622145
- Cited by
- 312
- References
- 50
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.